JavaScript is disabled for your browser. Some features of this site may not work without it.
Precision medicine in type 2 diabetes: harnessing individual-level trial data alongside routine care records to identify predictors of response to SGLT2 inhibitors and DPP4 inhibitors
Dennis, JM; Henley, W; Jones, A; et al.McGovern, A; Pearson, E; Hattersley, A; Shields, B